1 |
Allen, D. L., Hittel, D. S. and McPherron, A. C. 2011. Expression and function of myostatin in obesity, diabetes, and exercise adaptation. Med. Sci. Sports Exerc. 43, 1828-1835.
DOI
|
2 |
Alsolmei, F. A., Li, H., Pereira, S. L., Krishnan, P., Johns, P. W. and Siddiqui, R. A. 2019. Polyphenol-enriched plum extract enhances myotubule formation and anabolism while attenuating colon cancer-induced cellular damage in C2C12 cells. Nutrients 11, 1077.
DOI
|
3 |
Barrett-Connor, E. 1995. Testosterone and risk factors for cardiovascular disease in men. Diabetes Metab. 21, 156-161.
|
4 |
Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M. and Hemmings, B. A. 1995. Inhibition of glycogen synthase kinase- 3 by insulin mediated by protein kinase B. Nature 378, 785-789.
DOI
|
5 |
Deldicque, L., Theisen, D., Bertrand, L., Hespel, P., Hue, L. and Francaux, M. 2007. Creatine enhances differentiation of myogenic C2C12 cells by activating both p38 and Akt/PKB pathways. Am. J. Physiol. Cell Physiol. 293, C1263-C1271.
DOI
|
6 |
Devol, D. L., Rotwein, P., Sadow, J. L., Novakofski, J. and Bechtel, P. J. 1990. Activation of insulin-like growth factor gene expression during work-induced skeletal muscle growth. Am. J. Physiol. 259, E89-E95.
|
7 |
Dinev, D., Jordan, B. W., Neufeld, B., Lee, J. D., Lindemann, D., Rapp, U. R. and Ludwig, S. 2001. Extracellular signal regulated kinase 5 (ERK5) is required for the differentiation of muscle cells. EMBO Rep. 2, 829-834.
DOI
|
8 |
Feldman, B. J., Streeper, R. S., Farese, R. V. and Yamamoto, K. R. 2006. Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects. Proc. Natl. Acad. Sci. USA. 103, 15675-15680.
DOI
|
9 |
Go, G. Y., Lee, S. J., Jo, A., Lee, J., Seo. D. W., Kang, J. S., Kim, S. K., Kim, S. N., Kim, T. K. and Bae, G. U. 2017. Ginsenoside Rg1 from Panax ginseng enhances myoblast differentiation and myotube growth. J. Ginseng. Res. 41, 608-614.
DOI
|
10 |
Gredinger, E., Gerber, A. N., Tamir, Y., Tapscott, S. J. and Bengal, E. 1998. Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells. J. Biol. Chem. 273, 10436-10444.
DOI
|
11 |
Grunfeld, C., Kotler, D. P., Dobs, A., Glesby, M., Bhasin, S. and Group, O. S. 2006. Oxandrolone in the treatment of HIV-associated weight loss in men: a randomized, doubleblind, placebo-controlled study. J. Acquir. Immune Defic. Syndr. 41, 304-314.
DOI
|
12 |
Hindi, S. M., Tajrishi, M. M. and Kumar, A. 2013. Signaling mechanisms in mammalian myoblast fusion. Sci. Signal. 6, 272.
DOI
|
13 |
Guo, T., Jou, W., Chanturiya, T., Portas, J., Gavrilova, O. and McPherron, A. C. 2009. Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity. PLoS One 4, 3.
|
14 |
Hall, R. C., Hall, R. C. and Chapman, M. J. 2005. Psychiatric complications of anabolic steroid abuse. Psychosomatics 46, 285-290.
DOI
|
15 |
Hamrick, M. W., McPherron, A. C. and Lovejoy, C. O. 2002. Bone mineral content and density in the humerus of adult myostatin-deficient mice. Calcif. Tissue Int. 71, 1.
DOI
|
16 |
Hwang, S. Y, Kang, Y. J., Sung, B., Kim, M., Kim, D. H., Lee, Y., Yoo, M. A., Kim, C. M., Chung, H. Y. and Kim, N. D. 2015. Folic acid promotes the myogenic differentiation of C2C12 murine myoblasts through the Akt signaling pathway. Int. J. Mol. Med. 36, 1073-1080.
DOI
|
17 |
Jung, H. Y., Kang, S. Y., Hyun, S. Y., Kwon, Y. and Park, Y. K. 2019. Effects of chaenomelis fructusextract on the regulation of myoblasts differentiation and the expression of biogenetic factors in C2C12 myotubes. Kor. J. Herbology 34, 99-107.
DOI
|
18 |
Jones, N. C., Fedorov, Y. V., Rosenthal, R. S. and Olwin, B. B. 2001. ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion. J. Cell. Physiol. 186, 104-115.
DOI
|
19 |
Kenny, A. M., Prestwood, K. M., Gruman, C. A., Marcello, K. M. and Raisz, L. G. 2001. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J. Am. Geriatr. Soc. 56, M266-M272.
|
20 |
Berger, J. R., Pall, L., Hall, C. D., Simpson, D. M., Berry, P. S. and Dudley, R. 1996. Oxandrolone in AIDS-wasting myopathy. AIDS 10, 1657-1662.
DOI
|
21 |
Bhatnagar, S., Kumar, A., Makonchuk, D. Y., Li, H. and Kumar, A. 2010. Transforming growth factor- -activated kinase 1 is an essential regulator of myogenic differentiation. J. Biol. Chem. 285, 6401-6411.
DOI
|
22 |
Bodine, S. C., Stiff, T. N., Gonzalez, M, Kline W. O., Stover, G. L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J. C., Glass, D. J. and Yancopoulos, G. D. 2001. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat. Cell Biol. 3, 1014-1019.
DOI
|
23 |
Cella, P. S., Marinello, P. C., Borqes, F. H., Ribeiro, D. F., Chimin, P., Testa, M. T. J., Guirro, P. B., Duarte, J. A., Cecchini, R., Guarnier, F. A. and Deminice, R. 2019. Creatine supplementation in Walker-256 tumor-bearing rats prevents skeletal muscle atrophy by attenuating systemic inflammation and protein degradation signaling. Eur. J. Nutr. doi: 10.1007/s00394-019-01933-6.
|
24 |
Chal, J. and Pourquie, O. 2017. Making muscle: skeletal myogenesis in vivo and in vitro. Development 144, 2104-2122.
DOI
|
25 |
Chang, L. and Karin, M. 2001. Mammalian MAP kinase signalling cascades. Nature 410, 37-40.
DOI
|
26 |
Cho, S., Hong, R., Yim, P., Yeom, M., Lee, B., Yang, W. M., Hong, J., Lee, H. S. and Hahm, D. H. 2018. An herbal formula consisting of Schisandra chinensis (Turcz.) Baill, Lycium chinense Mill and Eucommia ulmoides Oliv alleviates disuse muscle atrophy in rats. J. Ethnopharmacol. 213, 328-339.
DOI
|
27 |
Choi, Y. K., et al. 2014. Effect of Sipjeondaebo-tang on cancer-induced anorexia and cachexia in CT-26 tumor-bearing mice. Mediators Inflamm. 2014,
|
28 |
Kjaer, M. 2004. Conversion of mechanical loading into functional adaptation of tendon and skeletal muscle: a role for extracellular matrix. Physiol. Rev. 84, 649-698.
DOI
|
29 |
Kim, A., Im, M., Gu, M. J. and Ma, J. Y. 2016. Citrus unshiu peel extract alleviates cancer-induced weight loss in mice bearing CT-26 adenocarcinoma. Sci. Rep. 6, 1-13.
DOI
|
30 |
Kim, A., Im, M. and Ma, J. Y. 2018. A novel herbal formula, SGE, induces endoplasmic reticulum stress-mediated cancer cell death and alleviates cachexia symptoms induced by colon-26 adenocarcinoma. Oncotarget 9, 16284.
DOI
|
31 |
L, Allen. D., Hittel, D. S. and McPherron, A. C. 2011. Expression and function of myostatin in obesity, diabetes, and exercise adaptation. Med. Sci. Sports Exerc. 43, 1828.
DOI
|
32 |
Lecker, S. H. and Mitch, W. E. 2011. Proteolysis by the ubiquitin-proteasome system and kidney disease. J. Am. Soc. Nephrol. 22, 821-824.
DOI
|
33 |
Lee, H. J., Heo, J. W., Kim, A. R., Kweon, M., Nam, S., Lim, J. S., Sung, M. K., Kim, S. E. and Ryu, J. H. 2019. Z-ajoene from crushed garlic alleviates cancer-induced skeletal muscle atrophy. Nutrients 11, 2724.
DOI
|
34 |
Lee, J. H., Tachibana, H., Morinaga, Y., Fujimura, Y. and Yamada, K. 2009. Modulation of proliferation and differentiation of C2C12 skeletal muscle cells by fatty acids. Life Sci. 84, 415-420.
DOI
|
35 |
Lee, S. J. and Glass, D. J. 2011. Treating cancer cachexia to treat cancer. Skelet. Muscle 1, 2.
DOI
|
36 |
Lee, S. J. and McPherron, A. C. 2001. Regulation of myostatin activity and muscle growth. Proc. Natl. Acad. Sci. USA. 98, 9306-9311.
DOI
|
37 |
Lin, J., Arnold, H. B., Della-Fera, M. A., Azain, M. J., Hartzell, D. L. and Baile, C. A. 2002. Myostatin knockout in mice increases myogenesis and decreases adipogenesis. Biochem. Biophys. Res. Commun. 291, 701-706.
DOI
|
38 |
Lee, S. Y., et al. 2018. Black ginseng activates Akt signaling, thereby enhancing myoblast differentiation and myotube growth. J. Ginseng Res. 42, 116-121.
DOI
|
39 |
Leevers, S., Weinkove, D., MacDougall, L., Hafen, E. and Waterfield, M. 1996. The Drosophila phosphoinositide 3-kinase Dp110 promotes cell growth. EMBO J. 15, 6584-6594.
DOI
|
40 |
Li, P., Liu, A., Xiongt, W., Lin, H., Xiao, W., Huang, J., Zhang, S. and Liu, Z. 2020. Catechins enhance skeletal muscle performance. Crit. Rev. Food. Sci. Nutr. 60, 515-528.
DOI
|
41 |
Loudon, J. K. 2006. Principles of pharmacology for athletic trainers. Phys. Ther. 86, 459-459.
DOI
|
42 |
Mathew, S. J. 2011. InACTIVatINg cancer cachexia. Dis. Model Mech. 4, 283-285.
DOI
|
43 |
Matsumoto, A. M. 1990. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production. J. Clin. Endocrinol. Metab. 70, 282-287.
DOI
|
44 |
McPherron, A. C. and Lee, S. J. 1997. Double muscling in cattle due to mutations in the myostatin gene. Proc. Natl. Acad. Sci. USA. 94, 12457-12461.
DOI
|
45 |
Melnik, B., Jansen, T. and Grabbe, S. 2007. Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem. J. Dtsch. Dermatol. Ges. 5, 110-117.
DOI
|
46 |
Pallafacchina, G., Calabria, E., Serrano, A. L., Kalhovde, J. M. and Schiaffino, S. 2002. A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc. Natl. Acad. Sci. USA. 99, 9213-9218.
DOI
|
47 |
Meriane, M., Roux, P., Primig, M., Fort, P. and Gauthier-Rouviere, C. 2000. Critical activities of Rac1 and Cdc42Hs in skeletal myogenesis: antagonistic effects of JNK and p38 pathways. Mol. Biol. Cell. 11, 2513-2528.
DOI
|
48 |
Meriggiola, M. C., Costantino, A., Bremner, W. J. and Morselli-Labate, A. M. 2002. Higher testosterone dose impairs sperm suppression induced by a combined androgen-progestin regimen. J. Androl. 23, 684-690.
|
49 |
Montagne, J., Stewart, M. J., Stocker, H., Hafen, E., Kozma, S. C. and Thomas, G. 1999. Drosophila S6 kinase: a regulator of cell size. Science 285, 2126-2129.
DOI
|
50 |
Perdiguero, E., Ruiz-Bonilla, V., Gresh, L., Hui, L., Ballestar, E., Sousa-Victor, P., Baeza-Raja, B., Jardi, M., Bosch-Comas, A., Esteller, M., Caelles, C, Serrano, A. L., Wagner, E. F. and Munoz-Canoves, P. 2007. Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of in abrogating myoblast proliferation. EMBO J. 26, 1245-1256.
DOI
|
51 |
Pratiwi, Y. S., , Lesmana, R., Goenawan, H., Sylviana, N., Setiawan, I., Tarawan, V. M., Lestari, K., Abdulah, R., Dwipa, L., Purba, A. and Supratman, U. 2018. Nutmeg extract increases skeletal muscle mass in aging rats partly via IGFl-AKT-mTOR pathway and inhibition of autophagy. Evid. Based Complement Alternat. Med. 2018, NA.
|
52 |
Rodgers, B. D. and Garikipati, D. K. 2008. Clinical, agricultural, and evolutionary biology of myostatin: a comparative review. Endocr. Rev. 29, 513-534.
DOI
|
53 |
Wang, Y., Ma, J., Qiu, W., Zhang, J., Feng, S., Zhou, X., Wang, X., Jin, L., Long, K., Liu, L., Xiao, W., Tang, Q., Zhu, L., Jiang, Y., Li, X. and Li, M. 2018. Guanidinoacetic acid regulates myogenic differentiation and muscle growth through miR-133a-3p and miR-1a-3p co-mediated Akt/mTOR/S6K signaling pathway. Int. J. Mol. Sci. 19, 792-800.
DOI
|
54 |
Rommel, C., Bodine, S. C., Clarke, B. A., Rossman, R., Nunez, L., Stitt, T. N., Yancopoulos, G. D. and Glass, D. J. 2001. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI (3) K/Akt/mTOR and PI (3) K/Akt/GSK3 pathways. Nat. Cell Biol. 3, 1009-1013.
DOI
|
55 |
Rommel, C., Bodine, S. C., Clarke, B. A., Rossman, R., Nunez, L., Stitt, T. N., Yancopoulos, G. D. and Glass, D. J. 2001. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI (3) K/Akt/mTOR and PI (3) K/Akt/GSK3 pathways. Nat. Cell Biol. 3, 1009-1013.
DOI
|
56 |
W, B. E., McNaughton, L. and Marshall-Gradisnik, S. M. 2011. Is there a potential immune dysfunction with anabolic androgenic steroid use?: A review. Mini Rev. Med. Chem. 11, 438-445.
DOI
|
57 |
Wu, Z., Woodring, P. J., Bhakta, K. S., Tamura, K., Wen, F., Feramisco, J. R., Karin, M., Wang, J. Y. and Puri, P. L. 2000. p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol. Cell. Biol. 20, 3951-3964.
DOI
|
58 |
Yamamoto, Y., Moore, R., Hess, H. A., Guo, G. L., Gonzalez, F. J., Korach, K. S., Maronpot, R. R. and Negishi, M. 2006. Estrogen receptor mediates -ethynylestradiol causing hepatotoxicity. J. Biol. Chem. 281, 16625-16631.
DOI
|
59 |
Zhang, H., Stallock, J. P., Ng, J. C., Reinhard, C. and Neufeld, T. P. 2000. Regulation of cellular growth by the Drosophila target of rapamycin dTOR. Genes Dev. 14, 2712-2724.
DOI
|
60 |
Zhao, B., Wall, R. J. and Yang, J. 2005. Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance. Biochem. Biophys. Res. Commun. 337, 248-255.
DOI
|
61 |
Ryan, T., Liu, J., Chu, A., Wang, L., Blais, A. and Skerjanc, I. S. 2012. Retinoic Acid enhances skeletal myogenesis in human embryonic stem cells by expanding the premyogenic progenitor population. Stem. Cell. Rev. Rep. 8, 482-493.
DOI
|
62 |
Senesi, P., Luzi, L., Montesano, A., Mazzocchi, N. and Terruzzi, I. 2013. Betaine supplement enhances skeletal muscle differentiation in murine myoblasts via IGF-1 signaling activation. J. Transl. Med. 11, 174.
DOI
|
63 |
Song, M. Y. 2015. Effect of root of atractylodes macrocephala Koidzumi on myogenesis in C2C12 cells. J. Kor. Med. Obes. Res. 15.1, 38-44.
DOI
|
64 |
Sung, B., Hwang, S. Y., Kim, M. J., Kim, M., Jeong, J. W., Kim, C. M., Chung, H. Y. and Kim, N. D. 2015. Loquat leaf extract enhances myogenic differentiation, improves muscle function and attenuates muscle loss in aged rats. Int. J. Mol. Med. 36, 792-800.
DOI
|
65 |
Turillazzi, E., Perilli, G., Di Paolo, M., Neri, M., Riezzo, I. and Fineschi, V. 2011. Side effects of AAS abuse: an overview. Mini. Rev. Med. Chem. 11, 374-389.
DOI
|
66 |
Tortorella, L. L., Milasincic, D. J. and Pilch, P. F. 2001. Critical proliferation-independent window for basic fibroblast growth factor repression of myogenesis via the p42/p44 MAPK signaling pathway. J. Biol. Chem. 276, 13709-13717.
DOI
|
67 |
Trendelenburg, A. U., Meyer, A., Rohner, D., Boyle, J., Hatakeyama, S. and Glass, D. J. 2009. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size. Am. J. Physiol. Cell Physiol. 296, C1258-C1270.
DOI
|
68 |
Trenton, A. J. and Currier, G. W. 2005. Behavioural manifestations of anabolic steroid use. CNS Drugs 19, 571-595.
DOI
|
69 |
Vivanco, I. and Sawyers, C. L. 2002. The phosphatidylinositol 3-kinase-AKT pathway in human cancer. Nat. Rev. Cancer 2, 489-501.
DOI
|